Endo is set to augment the firm’s commercial portfolio and pipeline of generic sterile injectables and ophthalmic drugs, as well as bolster its manufacturing capabilities, after agreeing to acquire New Jersey based Somerset Therapeutics and its contract development and manufacturing business, India’s Wintac, for around US$190 million.
Endo is set to augment the firm’s commercial portfolio and pipeline of generic sterile injectables and ophthalmic drugs, as well as bolster its manufacturing capabilities, after agreeing to acquire New Jersey based Somerset Therapeutics and its contract development and manufacturing business, India’s Wintac, for around US$190 million.
Subject to regulatory approvals in both the US and India, as well as customary closing conditions, the transaction is scheduled...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
